NURVAQAY
RegisteredWord Mark
•
Ownership
GG
Owner Name
Type: Organization / Private Company Limited by Shares
Address
GSK Medicines Research Centre, Gunnels Wood Road
Stevenage, SG12NY
United Kingdom
Critical Dates
First Use Date
Not filed yet
Filing Date
Sep 3, 2025
Registration Date
Feb 10, 2026
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological...
Mark Elements
Text Mark
NURVAQAY
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 12:11 PMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
NURVAQAY is a standard character mark covering pharmaceuticals in Class 005, including preparations for treating damaged skin and tissue, pain, inflammation, obesity, infectious diseases, and various conditions such as viral, metabolic, cardiovascular, oncological, and immune system disorders, along with vaccines and anti-infectives; it spans additional classes 006, 018, 044, 046, 051, and 052. The mark is owned by Glaxo Group Limited, a UK private company limited by shares based at GSK Medicines Research Centre in Stevenage, UK. It is currently registered on the Principal Register, with registration number 8137357 issued on February 10, 2026, claiming priority from a UK registration (UK00004253150) filed and registered on August 22, 2025.
Recent Activity
Filed on September 3, 2025, the application faced a suspension inquiry in October 2025, to which applicant responded in November, leading to approval for publication on November 25, 2025. It was published for opposition on December 23, 2025, with no oppositions filed, and registered on February 10, 2026.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach